DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Drug of last resort
Drug of last resort
Combinatorial Use of Marr Inhibitor with Efflux Pump Inhibitor
Psychoactive Drug Classifications
(19) United States (12) Patent Application Publication (10) Pub
BAD BUGS, NO DRUGS As Antibiotic Discovery Stagnates
Current Status of Symptomatic Medical Therapy in Parkinson’
Staphylococcus Aureus Infections in Malaysia: a Review of Antimicrobial Resistance and Characteristics of the Clinical Isolates, 1990–2017
March 2015 - Medical Department in This Issue – Rational Use of Drugs
Heightened Surveillance of Chloramphenicol Residues in Shrimp « Global Aquaculture Advocate
Antimicrobial Resistance
IDSA Letter to WHO on Prioritizing Antimicrobial Resistant Pathogens
Epidemiology of Β-Lactamase-Producing Enterobacteriaceae in Humans and Livestock
Vancomycin-Resistant Staphylococcus Aureus: Formidable Threat Or Silence Before the Storm? Helen Kest1* and Ashlesha Kaushik2
Discovery of Small-Molecule Inhibitors of Multidrug-Resistance Plasmid Maintenance Using a High-Throughput Screening Approach
Understanding Antibiotic Resistance
Successful High-Dosage Monotherapy of Tigecycline in a Multidrug-Resistant Klebsiella Pneumoniae Pneumonia–Septicemia Model in Rats
In Vitro Synergy of Isavuconazole in Combination with Colistin Against Candida Auris Patrick Schwarz 1,2*, Anne‑Laure Bidaud3 & Eric Dannaoui 3,4
IDSA Testimony E&C ABX Hearing Sept 19 2014 FINAL
The Continuing Threat of Methicillin-Resistant Staphylococcus Aureus- Past Present Future
Top View
Antibacterial Discovery: 21St Century Challenges
JMSCR Vol||07||Issue||06||Page 848-854||June 2019
Summer 2019 Issue of the Association of Public
History of Additional Plasma Metabolic Profile Data Submitted by the Firm HISTORY
A REVIEW on EMERGENCE of ANTIBIOTIC RESISTANT Staphylococcus Aureus and ROLE of CHITOSAN NANOPARTICLE in DRUG DELIVERY
The Antibiotic Resistance Crisis Part 1: Causes and Threats C
Frequently Asked Questions
Pass Assured's Pharmacy Technician Training Program
MRSA Uses Decoys to Evade a Last-Resort Antibiotic 24 October 2016
Linezolid Compared with Vancomycin for the Prevention of Methicillin
Antimicrobial Resistance of Enterococcus Sp. Isolated from Sheep and Goat Cheeses
Antibiotics 4Th Class
Overcoming Resistance Causes Food Poisoning
Simplifying Systemic Antibiotics Principles of Antimicrobial Therapy
Antimicrobial Characterization and Therapeutic Applications of Novel
Antibiotics and Antibiotic Resistance
Glycopeptide Antibiotics: Back to the Future
Gene in Escherichia Coli Isolates from Port Harcourt, Nigeria
Susceptibility of Methicillin Resistant Staphylococcus Aureus To
Antimicrobial Resistance History and Perspectives
A Scientific Roadmap for Antibiotic Discovery
Structural Alert/Reactive Metabolite Concept As Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxici
Emergence of Metallo-Β-Lactamases in Enterobacteriaceae from Argentina
Current Situation Regarding Infections Caused by Bacteria, With
Antimicrobial Peptides for Topical Treatment of Osteomyelitis and Implant-Related Infections: Study in the Spongy Bone
Synthesis and in Vitro Evaluation of the Antitubercular and Antibacterial Activity of Novel Oxazolidinones Bearing Octahydrocyclopenta[C]Pyrrol-2-Yl Moieties
Simplifying Systemic Antibiotics Principles of Antimicrobial Therapy
Discovery of Breakthrough Antibiotic Compounds 27 Sep 2016
NMRSARL Annual Report 2016
Antibiotics 4Th Class
Today, Colistin Is Used As Drug of Last Resort in Cases That Are Not Curable by Standard Antibiotic Therapy